Apogee Therapeutics, Inc. Increase Decrease In Operating Lease Liability
Apogee Therapeutics, Inc. (APGE) reported Increase Decrease In Operating Lease Liability of -$2.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$1.21M.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$802.00K.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$1.00M.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$992.00K.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2025 was -$3.98M.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.04M.
- Apogee Therapeutics, Inc. increase decrease in operating lease liability for fiscal 2023 was -$270.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.02M 10-Q · filed 2026-08-10 | -$3.02M derived: sum of 3 quarters · filed 2026-08-10 | -$4.01M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$802.00K 10-Q · filed 2026-05-11 | -$1.81M derived: sum of 2 quarters · filed 2026-05-11 | -$2.80M derived: sum of 3 quarters · filed 2026-05-11 | -$3.77M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$2.00M derived: sum of 2 quarters · filed 2026-03-02 | -$2.97M derived: sum of 3 quarters · filed 2026-08-10 | -$3.98M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.96M derived: sum of 2 quarters · filed 2026-08-10 | -$2.98M 10-Q · filed 2025-11-10 | -$3.29M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$971.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.99M 10-Q · filed 2026-08-10 | -$2.29M derived: sum of 3 quarters · filed 2026-08-10 | -$2.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$1.01M 10-Q · filed 2026-05-11 | -$1.32M derived: sum of 2 quarters · filed 2026-05-11 | -$1.55M derived: sum of 3 quarters · filed 2026-05-11 | -$1.80M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$538.00K derived: sum of 2 quarters · filed 2026-03-02 | -$782.00K derived: sum of 3 quarters · filed 2026-03-02 | -$1.04M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$473.00K derived: sum of 2 quarters · filed 2025-11-10 | -$736.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$507.00K 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$263.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$270.00K 10-K · filed 2026-03-02 |